Inghams Group Ltd (ASX:ING) Shares Fall 5% As Profit Slumps

Today Inghams Group Ltd (ASX:ING) shares fell 5% after it released half-year results to the ASX.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

Today Inghams Group Ltd

online pharmacy keflex for sale no prescription

(ASX: ING) shares fell 5% after it released half-year results to the market with underlying net profit after tax (NPAT) down 5.3% to $55.4 million.

Inghams is an integrated poultry producer operating in the Australia and New Zealand markets.

Key Results

Inghams reported:

  • Core Poultry volumes increased 3% to 207.5kt
  • Underlying EBITDA up 3.6% to $109.6 million
  • Underlying NPAT down 5.3% to $55.4 million
  • Cash flow from operations $102.8 million
  • An interim dividend of 9 cents per share (cps) fully franked

During the year, Inghams divested of its horse feed business Mitavite booking a pre-tax profit of ~$50 million which has been excluded in the underlying results. This was partially offset by restructuring initiatives of $11.4 million and impairment of $2.3 million which were also excluded from underlying results.

Management Commentary

Inghams CEO Jim Leighton said, “the results are pleasing and reflect further progress on our strategy implementation and the continued demand for Ingham’s quality products”.

Mr Leighton mentioned the impact of the drought conditions in Australia, saying, “the first half saw significant cost increases relating to feed driven by the drought conditions in Australia and while every effort was made to offset these increases through internal initiatives, ultimately these were passed through to the market

online pharmacy buy keflex no prescription pharmacy

”.

Share Buyback

Inghams reaffirmed an on-market share buyback announced in December using the proceeds from the sale of Mitavite business. The company expects to buy back up to $50 million worth of shares.

Outlook

Inghams stopped short of providing any guidance on numbers. However, it said it expects demand to “grow at historical levels” and expects feed costs to remain high until December. It also continues to implement Project Accelerate to try and gain efficiencies which is expected to be completed by the end of the current financial year.

Rask Perspective

Inghams is a company that has little pricing power for its products. As such as I have no interest in adding this stock to my portfolio for the long run, especially when we consider there are 2,000+ other shares on the market.

[ls_content_block id=”14945″ para=”paragraphs”]

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.